What does SANIMED do?

SANIMED is a pharmacy in Oudenburg. Private Limited, started on 27 November 1992, 1 establishment.

What is the address of SANIMED?

The registered office of SANIMED is located at Dorpsstraat 99, 8460 Oudenburg.

Is SANIMED still active?

Yes. According to the CBE (29 October 2026) SANIMED is active, legal situation “Normale toestand”, started on 27 November 1992.

Is SANIMED registered on Peppol?

Yes, SANIMED is registered on the Peppol network with ID 0208:0448804548.

What is the enterprise number of SANIMED?

The enterprise number of SANIMED is BE0448804548.

When was SANIMED founded?

SANIMED was founded on 27 November 1992.

Who are the directors of SANIMED?

According to the 2025 annual accounts, the directors of SANIMED are: Sodiap BV, Alexo BV.

Is SANIMED a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 November 1992; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did SANIMED make in 2025?

SANIMED posted a profit after taxes of € 28,974 in financial year 2025.

What is the revenue of SANIMED?

As a small company, SANIMED is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 295,346.

How much does an employee at SANIMED earn?

The average wage cost per full-time employee at SANIMED was € 72,100 in 2025: staff costs of € 230,672 for 3.2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does SANIMED have?

According to the 2025 annual accounts, SANIMED has 3.2 full-time equivalents (FTE).

Does SANIMED have a website?

Yes, SANIMED has a website at apotheeksanimed.be.

SANIMED (Private Limited) - Oudenburg - BE0448804548

Dossier SANIMED, printed on 29 October 2026 from databakkes.be/en/0448804548/sanimed. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

SANIMED from Oudenburg, company number BE0448804548, closed financial year 2025 with a result of € 28,974 after tax. For that financial year SANIMED recorded a gross margin of € 295,346 and equity of € 619,306. Compared with financial year 2024, the result moved from € 8,296 to € 28,974. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 12, 2026.

What it is worth Growing

€ 619,306

▲ 5% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 28,974

▲ 249% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 8,668

▼ 9% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 600,706.

People and assets in 2025

Full-time equivalents

3.2

▼ 0.8 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 230,672

▼ 2% vs 2024

€ 72,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 6,611

▲ 16% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 139,675

▼ 8% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 27,257

▼ 4% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 339,438 Gross margin 2022: € 339,438 First fiscal year in the series	€ 294,402 Gross margin 2023: € 294,402 ▼ 13% vs 2022 (€ 339,438) Unfavourable step	€ 271,306 Gross margin 2024: € 271,306 ▼ 8% vs 2023 (€ 294,402) Unfavourable step	€ 295,346 Gross margin 2025: € 295,346 ▲ 9% vs 2024 (€ 271,306) Favourable step	▲ 9%
Profit after taxes	€ 95,598 Profit after taxes 2022: € 95,598 First fiscal year in the series	€ 35,151 Profit after taxes 2023: € 35,151 ▼ 63% vs 2022 (€ 95,598) Unfavourable step	€ 8,296 Profit after taxes 2024: € 8,296 ▼ 76% vs 2023 (€ 35,151) Unfavourable step	€ 28,974 Profit after taxes 2025: € 28,974 ▲ 249% vs 2024 (€ 8,296) Favourable step	▲ 249%
Equity	€ 1,644,886 Equity 2022: € 1,644,886 First fiscal year in the series	€ 582,037 Equity 2023: € 582,037 ▼ 65% vs 2022 (€ 1,644,886) Unfavourable step	€ 590,333 Equity 2024: € 590,333 ▲ 1% vs 2023 (€ 582,037) Favourable step	€ 619,306 Equity 2025: € 619,306 ▲ 5% vs 2024 (€ 590,333) Favourable step	▲ 5%
Total debts	€ 193,481 Total debts 2022: € 193,481 First fiscal year in the series	€ 178,682 Total debts 2023: € 178,682 ▼ 8% vs 2022 (€ 193,481) Favourable step	€ 179,988 Total debts 2024: € 179,988 ▲ 1% vs 2023 (€ 178,682) Unfavourable step	€ 166,932 Total debts 2025: € 166,932 ▼ 7% vs 2024 (€ 179,988) Favourable step	▼ 7%
Cash	€ 9,421 Cash 2022: € 9,421 First fiscal year in the series	€ 14,307 Cash 2023: € 14,307 ▲ 52% vs 2022 (€ 9,421) Favourable step	€ 9,564 Cash 2024: € 9,564 ▼ 33% vs 2023 (€ 14,307) Unfavourable step	€ 8,668 Cash 2025: € 8,668 ▼ 9% vs 2024 (€ 9,564) Unfavourable step	▼ 9%
Land & buildings	€ 51,409 Land & buildings 2022: € 51,409 First fiscal year in the series	€ 76,482 Land & buildings 2023: € 76,482 ▲ 49% vs 2022 (€ 51,409) Unchanged	€ 69,033 Land & buildings 2024: € 69,033 ▼ 10% vs 2023 (€ 76,482) Unchanged	€ 61,584 Land & buildings 2025: € 61,584 ▼ 11% vs 2024 (€ 69,033) Unchanged	▼ 11%
Retained profit	€ 1,626,286 Retained profit 2022: € 1,626,286 First fiscal year in the series	€ 563,437 Retained profit 2023: € 563,437 ▼ 65% vs 2022 (€ 1,626,286) Unfavourable step	€ 571,733 Retained profit 2024: € 571,733 ▲ 1% vs 2023 (€ 563,437) Favourable step	€ 600,706 Retained profit 2025: € 600,706 ▲ 5% vs 2024 (€ 571,733) Favourable step	▲ 5%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 1,098,000 Dividend 2023: € 1,098,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 1,098,000) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 1,838,367 Balance sheet total 2022: € 1,838,367 First fiscal year in the series	€ 760,719 Balance sheet total 2023: € 760,719 ▼ 59% vs 2022 (€ 1,838,367) Unchanged	€ 770,321 Balance sheet total 2024: € 770,321 ▲ 1% vs 2023 (€ 760,719) Unchanged	€ 786,238 Balance sheet total 2025: € 786,238 ▲ 2% vs 2024 (€ 770,321) Unchanged	▲ 2%
Employees (FTE)	3.8 Employees (FTE) 2022: 3.8 First fiscal year in the series	4 Employees (FTE) 2023: 4 ▲ 0.2 vs 2022 (3.8) Unchanged	4 Employees (FTE) 2024: 4 Unchanged (4) Unchanged	3.2 Employees (FTE) 2025: 3.2 ▼ 0.8 vs 2024 (4) Unchanged	▼ 0.8

Key figures of SANIMED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to SANIMED?

What happened at SANIMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 12, 2026 New annual accounts for financial year 2025: profit of € 28,974 (▲ 249% vs 2024). Source: NBB ↗
2022 Alexo BV became a director. NBB
2020 Sodiap BV became a director. NBB
Jun 14, 1993 New establishment in Oudenburg. KBO
Nov 27, 1992 Start of the company according to the CBE. KBO

In short

From € 95,598 profit in 2022 to € 28,974 profit in 2025.

Paid € 71,815 in corporate taxes since 2022.

Best year ever: 2022, with € 95,598 profit.

On average € 92,300 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

SODIAP 100%

The stake of SODIAP comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

SANIMED

Behind SANIMED are Sodiap BV and Alexo BV. The shares are held by SODIAP (100%).

Directors

According to the 2025 annual accounts

Sodiap BV

Managing director · represented by Tom Goderis

Also active at: SDC, HC Pharma, APOTHEEK JENNE, Apotheek de Lisseweg, Apotheek Seurinck, APOTHEEK SCARPHOUT, C.E. FARMA, SANIFAR +24 more

since 2020

Alexo BV

Chairman of the board · represented by Olivier Delaere

Also active at: SDC, HC Pharma, SODIAP, APOTHEEK JENNE, PANNOC CHEMIE, Apotheek de Lisseweg, Apotheek Seurinck, APOTHEEK SCARPHOUT +34 more

since 2022

Shareholders

SODIAP

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Dorpsstraat 99

8460 Oudenburg

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS apotheeksanimed.be

About

Technologies

AMPAlpine.jsCookie ConsentGoogle FontsNginxPlausibleVimeoYouTube EmbedreCAPTCHA

Hosting & Email

Email provider

Microsoft 365

Hosting

UPCLOUD, FI

Website info

HTTPS Ja

Indexable pages 109,752

Languages FR, NL

Features

Webshop Newsletter

Security

✓ HTTPS

✓ SPF

✗ DMARC

Network

✓ IPv6

Details

Company number

0448.804.548

VAT number

BE 0448.804.548

Registered office

Dorpsstraat 99, 8460 Oudenburg

Names & denominations

SANIMED

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

27 November 1992

Peppol

Active · Active since 6 Jun 2025

Contact

apotheeksanimed.be

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

SANIMED

Financials

What happened to SANIMED?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Website

Technologies

Hosting & Email

Website info

Features

Security

Network

Details

Frequently asked questions